Company: BDRX
Filing Date: 2025-01-21
Form Type: 424B3
Source: 0001214659-25-000933
Chunk: 2

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-21
Form: 424B3
Chunk 2
---
 pay to the Purchaser a fee of $875,000
in cash (the “Commitment Fee”), of which (i) $612,500 shall be paid to the Purchaser concurrently with the execution of the
Purchase Agreement and (ii) the balance of such Commitment Fee shall be paid to the Purchaser, in a pro rata fashion, simultaneously with
the delivery of any Purchase Shares under the Purchase Agreement (each, a “Commitment Fee Payment Date”). If the Company were
to fail to pay the applicable portion of the Commitment Fee to the Purchaser on the applicable Commitment Fee Payment Date, the Company
has the right, in its sole discretion, to issue Depositary Shares representing the value of the applicable portion of the Commitment Fee
(the “Commitment Shares,” and together with the Purchase Shares, the “Securities”) to release the Company of its
liability to pay the Commitment Fee, valued at the closing sale price of the Depositary Shares on the trading day immediately prior to
the date of the Purchase Agreement.

The
Company does not have a right to commence any sales of Depositary Shares to the Purchaser under the Purchase Agreement until the time
when all of the conditions to the Company’s right to commence sales of Depositary Shares to the Purchaser set forth in the Purchase
Agreement have been satisfied, including that a registration statement covering the resale of the Securities is declared effective by
the United States Securities and Exchange Commission (the “SEC”) and the final form of prospectus contained therein is filed
with the SEC (the “Commencement Date”).

Over
the 36-month period from and after the Commencement Date (unless the Purchase Agreement is terminated earlier in accordance with its terms),
the Purchaser has no right to require the Company to sell any Depositary Shares to the Purchaser, but the Purchaser is obligated to make
purchases as the Company directs, subject to certain conditions. There are no upper limits on the price per share that the Purchaser must
pay for the Depositary Shares. Actual sales of Depositary Shares to the Purchaser will depend on a variety of factors to be determined
by the Company from time to time, including, among others, market conditions, the trading price of the Company’s Depositary Shares
and determinations by the Company as to the appropriate sources of funding for the Company and its operations.

At
any time from and after the Commencement Date, on any business day on which the